ArticleAsia-Pacific journal of clinical oncology2026
Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter Study.
Samantha Kurniawan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.